Sluggish patient recruitment is costing the clinical research industry hundreds of millions of dollars in missed opportunity costs.

Informed consent is the process through which a potential subject is informed about a clinical research study and volunteers to

Sponsors have long debated whether or not to collect pre-screening and screening data for sites participating in their trials. Understandably this is a burden on the site, having to record screening efforts in real time and upload them to the sponsor on a weekly, bi-weekly or monthly basis. However, the utility of this data in shaping and pivoting your recruitment program in invaluable. Beyond the use of this dataset in the current trial, sponsors can leverage this data to better understand patient populations in this indication as well as better assess sites for future trials.

The Patient Recruitment Specialist (PRS) is a fairly new and emerging role in the clinical research industry. Their role varies between trials and sponsors though their primary duty